# BYQLOVI
> **NDA218158** · New Drug Application · Sponsor: HARROW EYE · Approved 2024-03-04
## Drug
- **FDA Application Number:** NDA218158
- **Application type:** New Drug Application
- **Brand name:** BYQLOVI
- **Generic name:** CLOBETASOL PROPIONATE
- **Active ingredients:** CLOBETASOL PROPIONATE
- **Dosage form:** SUSPENSION/DROPS
- **Route:** OPHTHALMIC
- **Marketing status:** Prescription
- **Sponsor:** HARROW EYE
- **Manufacturer:** Eyenovia, Inc.
- **First approval:** 2024-03-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218158)
---
*AI Analytics · CC0 1.0*